alexa Levels of Interleukin-17 and Interleukin-23 in Patients
ISSN: 2469-9756

Immunochemistry & Immunopathology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Levels of Interleukin-17 and Interleukin-23 in Patients with Systemic Lupus Erythematosus (SLE) in Trinidad and Tobago

Alisa Nobee1, Angel Justiz-Vaillant1*, Patrick E Akpaka1 and Peter Poon-King2

1Department of Para-Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, Trinidad and Tobago, West Indies

2San Fernando General Hospital, San Fernando, Trinidad and Tobago, West Indies

*Corresponding Author:
Angel Justiz-Vaillant
Department of Para-Clinical Sciences
Faculty of Medical Sciences
The University of the West Indies
Trinidad and Tobago, West Indies
Tel: +868-773-5914
E-mail: [email protected]

Received date: February 12, 2016; Accepted date: February 27, 2016; Published date: March 03, 2016

Citation: Nobee A, Justiz-Vaillant A, Akpaka PE, Poon-King P (2016) Levels of Interleukin 17 and 23 in Patients with Systemic Lupus Erythematosus (SLE) in Trinidad and Tobago. Immunochem Immunopathol 2:115. doi: 10.4172/2469-9756.1000115

Copyright: © 2016 Nobee A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Serum interleukin (IL)-17 and IL-23 and their association with systemic lupus erythematosus (SLE) is not well understood. A prospective cross sectional and observational study was done using twenty eight (28) SLE patients and fourteen (14) non SLE control subjects. Blood samples were taken to delineate the presence of IL-17 and IL-23 using ELISA among patients of the Rheumatology out-patient clinic at the San Fernando General Hospital, Trinidad and Tobago. The Systemic lupus erythematosus disease activity index (SLEDAI) 2000 score was used for evaluation of activity of the disease. It was found that of all the SLE patients 13 patients (47%) were of Afro-Trinidadian descent, 11 patients (39%) were of Indo-Trinidadian descent and 4 patients (14%) were of mixed descent. The majority of patients were within the 31-35 year age group. Serum IL-17 and IL-23 levels were greater in SLE patients compared to healthy subjects and their levels showed a positive correlation to SLEDAI score. However further experiments are needed to elucidate the role of IL-17 and IL-23 in SLE patients from Trinidad and Tobago.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords